Safety and efficacy of bupropion, a novel antidepressant
- 1 January 1985
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 6 (1), 39-45
- https://doi.org/10.1002/ddr.430060105
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Role of the HTLV-1 viral factors in the induction of apoptosisBiomedicine & Pharmacotherapy, 2017
- Bupropion HydrochlorideDrug Intelligence & Clinical Pharmacy, 1984
- Bupropion: A new antidepressant drug, the mechanism of action of which is not associated with down-regulation of postsynaptic β-adrenergic, serotonergic (5-HT2), α2-adrenergic, imipramine and dopaminergic receptors in brainNeuropharmacology, 1983
- Daily bupropion injections for 3 weeks attenuate the ne-stimulation of adenylate cyclase and the number of β-adrenergic recognition sites in rat frontal cortexNeuropharmacology, 1983
- Perceptual changes with bupropion, a novel antidepressantAmerican Journal of Psychiatry, 1982
- Some neurochemical properties of a new antidepressant, bupropion hydrochloride (Wellbutrin™)Drug Development Research, 1981
- The effect of psychoactive drugs on beta-adrenergic receptor binding sites in rat brainNeuropharmacology, 1980
- Bupropion hydrochloride ((±) α-t-butylamino-3-chloropropiophenone HCl): a novel antidepressant agentJournal of Pharmacy and Pharmacology, 1977
- Development of a Rating Scale for Primary Depressive IllnessBritish Journal of Social and Clinical Psychology, 1967
- A Self-Rating Depression ScaleArchives of General Psychiatry, 1965